Intravenous Low-Dose Iron Administration in Hemodialysis Patients Treated with Erythropoietin

Publisher： Karger

E-ISSN： 2235-3186|80|3|369-370

ISSN： 1660-8151

Source： Nephron, Vol.80, Iss.3, 1998-11, pp. : 369-370

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Intravenous Low-Dose Iron Administration in Hemodialysis Patients Treated with Erythropoietin: 1-Year Follow-Up Study

By  

Nephron, Vol. 86, Iss. 2, 2000-09 ,pp. : 200-201

Karger

Access to resources Recommend Favorite

Oral Low-Dose Ferric Citrate Is a Useful Iron Source for Hyperphosphatemic Hemodialysis Patients: A Case Series

By  

Blood Purification, Vol. 43, Iss. 1-3, 2016-12 ,pp. : 97-100

Karger

Access to resources Recommend Favorite

Effect of Weekly or Successive Iron Supplementation on Erythropoietin Doses in Patients Receiving Hemodialysis

By  

Nephron, Vol. 89, Iss. 1, 2001-08 ,pp. : 110-112

Karger

Access to resources Recommend Favorite

Intravenous Iron Sucrose in Chinese Hemodialysis Patients with Renal Anemia

By  

Blood Purification, Vol. 26, Iss. 2, 2008-01 ,pp. : 151-156

Karger

Access to resources Recommend Favorite

Erythropoietin-Induced Epilepsy in Hemodialysis Patients?

By  

Nephron, Vol. 78, Iss. 3, 1998-02 ,pp. : 354-354

Karger

Access to resources Recommend Favorite